The original report describes effects on lipid peroxidation and antioxidant systems in rats, alongside laboratory oxidation assays.
Study notes · methods, sources and limitations
Participants or model Rat acute-hypoxia experiments and in-vitro oxidation assays
Important limitations
Experimental antioxidant signals do not establish human efficacy, endurance or safety. Animal and isolated-system findings must remain separate from clinical research.
Biomeditsinskaya Khimiya. 49(5):434–442. PMID 16119095 · Publication record
An experimental thiobenzimidazole actoprotector investigated in rat hypoxia and laboratory oxidation models. Human clinical effectiveness is not established by the sources in this collection.
Research background
Experimental actoprotector with an original rat-hypoxia and in-vitro antioxidant report. Human clinical benefit is not established by this source.
Review dates and the material assessed are listed with each publication below.
02 / HOW TO READ THE RESEARCH
Understanding the evidence
Human research
No verified human clinical trial entered
Study methods
Not assessed
Independent replication
Not assessed
Source access
Publisher abstract and original citation
Safety evidence
Not assessed
Open a topic for the evidence assessment.
More findings, background and history
What remains unclear
The available experimental studies leave human benefit and safety uncertain.
No human intervention report has been identified among the linked records; unclassified archival leads may remain. Several publications can describe the same participants.
The 2003 publisher record documents rat hypoxia and in-vitro antioxidant work. This supplies a traceable experimental source rather than a name alone.
What remains unresolved
Recover complete methods, preparation chemistry and replication. The 2019 monograph explicitly pairs etomerzol and tomerzol on p. 266; confirm the preparation in each earlier report and do not infer human benefit.